Related references
Note: Only part of the references are listed.Lipogenesis inhibitors: therapeutic opportunities and challenges
Battsetseg Batchuluun et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)
Brad T. Sherman et al.
NUCLEIC ACIDS RESEARCH (2022)
The phosphorylation of AMPKß1 is critical for increasing autophagy and maintaining mitochondrial homeostasis in response to fatty acids
Eric M. Desjardins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis
Pascale Gluais-Dagorn et al.
HEPATOLOGY COMMUNICATIONS (2022)
Salicylates Ameliorate Intestinal Inflammation by Activating Macrophage AMPK
Suhrid Banskota et al.
INFLAMMATORY BOWEL DISEASES (2021)
Salsalate reduces atherosclerosis through AMPKβ1 in mice
Emily A. Day et al.
MOLECULAR METABOLISM (2021)
The changing landscape of atherosclerosis
Peter Libby
NATURE (2021)
Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo- controlled, phase 2a study
Kenneth Cusi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice
Emily A. Day et al.
BIOCHEMICAL JOURNAL (2020)
Myeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice
Nicholas D. LeBlond et al.
JOURNAL OF LIPID RESEARCH (2020)
Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK β1 isoforms
Stephen L. Pinkosky et al.
NATURE METABOLISM (2020)
AMP-activated protein kinase: the current landscape for drug development
Gregory R. Steinberg et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase
Danqing Feng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
Ryan M. Esquejo et al.
EBIOMEDICINE (2018)
Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2018)
AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation
Miao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Emily A. Day et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification
Claudia Goettsch et al.
ATHEROSCLEROSIS (2016)
MultiQC: summarize analysis results for multiple tools and samples in a single report
Philip Ewels et al.
BIOINFORMATICS (2016)
Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function
Emilio P. Mottillo et al.
CELL METABOLISM (2016)
Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice
Qiang Cao et al.
DIABETES (2016)
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy
Kimberly O. Cameron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
Stephen L. Pinkosky et al.
NATURE COMMUNICATIONS (2016)
Salicylate improves macrophage cholesterol homeostasis via activation of Ampk
Morgan D. Fullerton et al.
JOURNAL OF LIPID RESEARCH (2015)
Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
Sathish Babu Vasamsetti et al.
DIABETES (2015)
Induction of Sustained Hypercholesterolemia by Single Adeno-Associated Virus-Mediated Gene Transfer of Mutant hPCSK9
Marta Roche-Molina et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Triglycerides and cardiovascular disease
Borge G. Nordestgaard et al.
LANCET (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Morgan D. Fullerton et al.
NATURE MEDICINE (2013)
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
Clinton S. Robbins et al.
NATURE MEDICINE (2013)
Macrophage Autophagy Plays a Protective Role in Advanced Atherosclerosis
Xianghai Liao et al.
CELL METABOLISM (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
Sandra Galic et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
AMPK beta 1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance
Nicolas Dzamko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Adenosine Monophosphate-activated Protein Kinase Induces Cholesterol Efflux from Macrophage-derived Foam Cells and Alleviates Atherosclerosis in Apolipoprotein E-deficient Mice
Dan Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase
Olga Goeransson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mouse models for atherosclerosis and pharmaceutical modifiers
Susanne Zadelaar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small g protein-p38 ALAPK pathway
T Senokuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)